TYROBP and colitis: According to recent studies, Tyrobp was identified as a probable upstream regulator of UC [78], and its knockout robustly attenuated the severity of DSS-induced colitis in mice, whereas its overexpression resulted in a striking exacerbation of colon damage caused by DSS [79].